KutzelniggALucchinettiCFStadelmannC. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain2005; 128: 2705–2712.
2.
FisnikuLKChardDTJacksonJS. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol2008; 64: 247–254.
3.
PortaccioEStromilloMLGorettiB. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology2009; 73: 498–503.
4.
CalabreseMRinaldiFMattisiI. The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology2011; 77: 257–263.
5.
CAMMS223 Trial Investigators, ColesAJCompstonDASelmajKW. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med2008; 359: 1786–1801.
